£1.0M
The funding will support the development of the Callavid drug-device combination for threatened miscarriage.
CL
Calla Lily Clinical Care
Developing advanced drug delivery systems for women's healthcare.
London, UK—Founded 2021
£1.0MTotal raised
Calla Lily Clinical Care is a certified B-Corporation developing a novel drug-device combination to improve treatment for threatened miscarriage.
Categories
Founders
LZ
Lara Zibners
Co-founder and Chair